Arq heads into its third-quarter report with an awkward contradiction. Last quarter, the activated carbon producer showed the cleanest profitability it has posted in some time, with gross margin climbing to 38.5% and adjusted EBITDA reaching $5.8 million in a seasonally soft period. Yet the stock has since fallen 26%, badly trailing a roughly flat S&P 500. The November 4 release, due after the close, is the first chance to show whether that margin recovery can carry through a seasonally stronger quarter, or whether the market's skepticism was justified.
The Street is looking for earnings of $0.04 a share on revenue of about $35.1 million. That revenue figure matches the year-ago quarter almost exactly, so the top line is expected to be flat. The story sits entirely below it: a swing from a $0.02 loss a year ago to a modest profit is what produces the eye-catching 300% expected EPS growth. Sequentially, the forecast implies a solid step up from the $29.9 million booked last quarter. That jump is consistent with the seasonal pattern and with management's view that a modest chemicals shortfall in the second quarter was a matter of timing rather than lost business. If that revenue fails to materialize now, the timing explanation becomes harder to defend.
Management reaffirmed full-year guidance of $120 million to $125 million in revenue and $17 million to $20 million in adjusted EBITDA. That makes this quarter less about a raise and more about trajectory. Another quarter of EBITDA in the vicinity of the second quarter's result, on higher volume, would keep the company comfortably on pace for its range and lend credibility to the bolder ambition of lifting adjusted EBITDA from the powdered activated carbon business alone by up to 50%, toward roughly $30 million, without any help from granular carbon. Gross margin holding in the high 30s is the key validation. A slide back toward the high 20s would suggest the second quarter benefited from unusual mix or a lighter cost load.
Several threads from the last call deserve updates. Pricing appears supportive, with a major competitor having announced increases of up to 25%, so evidence that Arq is capturing that environment in its average selling prices would strengthen the margin case. The new CFO identified five categories of non-personnel cost cuts, and early signs of savings, along with the fading of severance and recruiting costs that inflated SG&A, would help operating leverage. The newly introduced PAC for PFAS product, aimed at water utilities just outside compliance, is a 2027 story, but progress on customer trials would show the catalyst is real. Corbin monetization, with third-party asphalt validation running through year end, remains optionality rather than an earnings driver.
The balance sheet is the pressure point. Unrestricted cash ended June at just $0.9 million before recovering to about $3.1 million a month later, while debt rose to $30.9 million. A cleaner cash position and stable or lower borrowings would ease a real overhang. The undecided granular carbon conversion, now scoped at $40 million to $60 million with no production expected in 2027, also looms; any hint of committing that capital without a clear funding plan could unsettle holders.
Sentiment has improved markedly, rising to about 45% bullish from 15% ahead of the prior report, but the chart tells a gloomier story. At $1.74, the stock is well below its 200-day average of $2.52 and just above its post-earnings low of $1.68, with a range that has shifted lower than the previous quarter's. That leaves room for relief if results confirm the turnaround. The central question is simple: can Arq convert seasonal volume into sustained high-30s margins and better cash generation, proving its core business can stand on its own?